30 September 2026
CAR T therapy has undergone a remarkable transformation over the past decade, evolving from an experimental treatment into a clinically validated therapeutic platform with seven FDA-approved therapies and a rapidly expanding global market estimated at $6 billion . . .
Click to read more
29 September 2026
Click to read more
07 September 2026
Cytomos has appointed life sciences executive Dr Alex Jones as a non-executive director as it moves to accelerate the commercialisation of its cell analysis technology.
Click to read more
To find out more about our revolutionary biotechnology, please click below and complete our form.
[gravityform id="1" title="false"]